BioPorto (BIOPOR)

Currency in DKK
0.960
+0.006(+0.63%)
Closed·
BIOPOR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.9340.974
52 wk Range
0.9201.620
Key Statistics
Prev. Close
0.954
Open
0.97
Day's Range
0.934-0.974
52 wk Range
0.92-1.62
Volume
311.29K
Average Volume (3m)
456.65K
1-Year Change
-36.5918%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOPOR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.000
Upside
+316.67%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

BioPorto News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

BioPorto Company Profile

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical chemistry analyzers to diagnose acute kidney injury; and antibodies to develop diagnostic immunoassays within disease areas, including immunodeficiency, allergy, coagulation, diabetes, kidney, and cardiovascular disease. The company also provides ready-to-use enzyme-linked immunosorbent assay (ELISA) kits to quantify NGAL in urine, plasma, and serum; and generic Rapid Assay Device (gRAD) for custom lateral flow assays. BioPorto A/S was founded in 1917 and is based in Hellerup, Denmark.

Compare BIOPOR to Peers and Sector

Metrics to compare
BIOPOR
Peers
Sector
Relationship
P/E Ratio
−5.4x12.7x−0.6x
PEG Ratio
0.210.030.00
Price/Book
13.4x1.1x2.6x
Price / LTM Sales
12.9x2.1x3.4x
Upside (Analyst Target)
321.1%15.7%44.9%
Fair Value Upside
Unlock2.3%6.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.000
(+316.67% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 19, 2025
EPS / Forecast
-0.05 / -0.04
Revenue / Forecast
10.41M / 14.50M
EPS Revisions
Last 90 days

BIOPOR Income Statement

People Also Watch

826.0
NKT
+1.47%
369.6
NOVOb
-0.22%
1,769.0
DSV
+0.94%
853.0
CARLb
+0.14%
11.66
BO
0.00%

FAQ

What Is the BioPorto (BIOPOR) Stock Price Today?

The BioPorto stock price today is 0.960

What Stock Exchange Does BioPorto Trade On?

BioPorto is listed and trades on the Copenhagen Stock Exchange stock exchange.

What Is the Stock Symbol for BioPorto?

The stock symbol for BioPorto is "BIOPOR."

What Is the BioPorto Market Cap?

As of today, BioPorto market cap is 475.29M.

What Is BioPorto's Earnings Per Share (TTM)?

The BioPorto EPS (TTM) is -0.20.

When Is the Next BioPorto Earnings Date?

BioPorto will release its next earnings report on Mar 17, 2026.

From a Technical Analysis Perspective, Is BIOPOR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BioPorto Stock Split?

BioPorto has split 3 times.

How Many Employees Does BioPorto Have?

BioPorto has 48 employees.

What is the current trading status of BioPorto (BIOPOR)?

As of Jan 30, 2026, BioPorto (BIOPOR) is trading at a price of 0.960, with a previous close of 0.954. The stock has fluctuated within a day range of 0.934 to 0.974, while its 52-week range spans from 0.920 to 1.620.

What Is BioPorto (BIOPOR) Price Target According to Analysts?

The average 12-month price target for BioPorto is DKK4.000, with a high estimate of DKK4 and a low estimate of DKK4. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +316.67% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.